Abstract | ||
---|---|---|
Early screening for cancer is arguably one of the greatest public health advances over the last fifty years. However, many cancer screening tests are invasive (digital rectal exams), expensive (mammograms, imaging) or both (colonoscopies). This has spurred growing interest in developing genomic signatures that can be used for cancer diagnosis and prognosis. However, progress has been slowed by heterogeneity in cancer profiles and the lack of effective computational prediction tools for this type of data. |
Year | DOI | Venue |
---|---|---|
2012 | 10.1186/1471-2105-13-272 | BMC Bioinformatics |
Keywords | Field | DocType |
Gene expression, Cancer, Genomic signatures, Microarray normalization and quality assessment, Anti-profiles | Cancer Screening Tests,Biology,Transcriptome,Genetic variation,Gene expression,Genomics,Bioinformatics,Genetics,DNA microarray,Gene expression profiling,Cancer | Journal |
Volume | Issue | ISSN |
13 | 1 | 1471-2105 |
Citations | PageRank | References |
11 | 0.66 | 6 |
Authors | ||
5 |
Name | Order | Citations | PageRank |
---|---|---|---|
Héctor Corrada Bravo | 1 | 79 | 6.78 |
Vasyl Pihur | 2 | 11 | 0.66 |
Matthew N. McCall | 3 | 65 | 6.98 |
Rafael A Irizarry | 4 | 1167 | 140.75 |
Jeffrey T. Leek | 5 | 148 | 13.79 |